Shopping Cart
Remove All
Your shopping cart is currently empty
Bempikibart (ADX-914) is a fully humanised monoclonal antibody targeting IL-7Rα, capable of inhibiting IL-17 and TSLP (Thymic stromal lymphopoietin), and may be employed in studies of cutaneous inflammation and alopecia.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $328 | - | In Stock | |
| 5 mg | $993 | - | In Stock | |
| 10 mg | $1,570 | - | In Stock | |
| 25 mg | $2,330 | - | In Stock | |
| 50 mg | $3,130 | - | In Stock |
| Description | Bempikibart (ADX-914) is a fully humanised monoclonal antibody targeting IL-7Rα, capable of inhibiting IL-17 and TSLP (Thymic stromal lymphopoietin), and may be employed in studies of cutaneous inflammation and alopecia. |
| Synonyms | ADX-914, ADX914 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | IL-7Ra/CD127 |
| Molecular Weight | 145.75 kDa |
| Cas No. | 2622254-57-1 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.